Exhibit 10.43 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR...Antares Pharma Inc • February 12th, 2003 • Surgical & medical instruments & apparatus • New York
Xmark Fund, L.P. 569,325 Warrant Shares 334,035 Debenture Shares Xmark Fund, Ltd. 1,680,675 Warrant Shares 940,164 Debenture Shares SDS Merchant Fund, LP 682,500 Warrant Shares 42,873 Debenture SharesRegistration Rights Agreement • February 12th, 2003 • Antares Pharma Inc • Surgical & medical instruments & apparatus • New York
Exhibit 10.40 DEBENTURE AND WARRANT PURCHASE AGREEMENT THIS DEBENTURE AND WARRANT PURCHASE AGREEMENT (the "Agreement") is made as of January 31, 2003, by and among Antares Pharma, Inc., a Minnesota corporation (the "Company"), Xmark Fund, L.P. and...Debenture and Warrant Purchase Agreement • February 12th, 2003 • Antares Pharma Inc • Surgical & medical instruments & apparatus • New York
Exhibit 10.42 AMENDED AND RESTATED SECURITY AGREEMENT AMENDED AND RESTATED SECURITY AGREEMENT (this "Agreement"), dated as of January 31, 2003, by and among Antares Pharma, Inc., a Minnesota corporation ("Company"), and the secured parties signatory...And Restated Security Agreement • February 12th, 2003 • Antares Pharma Inc • Surgical & medical instruments & apparatus • New York
Exhibit 10.46 PROMISSORY NOTE $_________________ Minneapolis, MinnesotaAntares Pharma Inc • February 12th, 2003 • Surgical & medical instruments & apparatus
FOR VALUE RECEIVED, the undersigned, Antares Pharma, Inc. ("Maker"), promises to pay to ____________________ ("Lender") or to its order, at _____________________________ (or at such other place as the holder hereof shall notify Maker in writing) the principal amount of _______________________________ ($______________) with interest from the date hereof on the unpaid principal balance hereunder at a rate equal to eight percent (8%) per annum. The principal amount and all accrued, but unpaid, interest shall be paid in full thirty (30) days from the date hereof in accordance with the terms set forth herein. This Note is unsecured in all respects; provided, however, this Note is exchangeable for Maker's new 8% Senior Secured Convertible Debentures (the "New Debt Securities") on the terms and conditions set forth in, and in connection with the consummation of the transactions contemplated by, that certain Term Sheet, dated January 22, 2003 (the "Term Sheet"), by and among Maker, Lender and
